Carol Juel
Known title: See remarksCIK: 0001868897
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
BHF Analyst Target Cut to $57, Rating Upgrade Amid Market Attention. KBW lowered its price target for BHF to $57, while a rating upgrade is expected after a pending acquisition. The stock has attracted attention following a 24% drop and its inclusion among life‑insurance names sensitive to rising Treasury yields. These developments add context to BHF’s valuation, which sits at a trailing P/E of 3.4 and an analyst average target of $65.
Transaction History
| SYF | ▲ Buy | Grant | 218 | $18K | 8/17/2026 | View on chart |
| SYF | ▲ Buy | Grant | 217 | $15K | 5/15/2026 | View on chart |
| BHF | ▲ Buy | Option Exercise | 3,361 | $0 | 5/1/2026 | View on chart |
| SYF | ▼ Sell | Open Market | 16,859 | $1.1M | 3/2/2026 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 14,561 | $1.0M | 3/1/2026 | View on chart |
| SYF | ▲ Buy | Grant | 24,093 | $1.7M | 3/1/2026 | View on chart |
| SYF | ▲ Buy | Grant | 243 | $18K | 2/17/2026 | View on chart |
| SYF | ▼ Sell | Open Market | 44,411 | $3.1M | 2/17/2026 | View on chart |
| SYF | ▲ Buy | Grant | 79,305 | $6.1M | 1/21/2026 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 34,894 | $2.7M | 1/21/2026 | View on chart |
| SYF | ▲ Buy | Grant | 249 | $18K | 11/17/2025 | View on chart |
| SYF | ▲ Buy | Grant | 244 | $17K | 8/15/2025 | View on chart |
| SYF | ▲ Buy | Grant | 287 | $17K | 5/15/2025 | View on chart |
| SYF | ▲ Buy | Option Exercise | 16,613 | $570K | 3/3/2025 | View on chart |
| SYF | ▲ Buy | Option Exercise | 18,145 | $608K | 3/3/2025 | View on chart |
| SYF | ▼ Sell | Open Market | 46,102 | $2.7M | 3/3/2025 | View on chart |
| SYF | ▼ Sell | Open Market | 13,177 | $757K | 3/3/2025 | View on chart |
| SYF | ▼ Sell | Open Market | 12,367 | $724K | 3/3/2025 | View on chart |
| SYF | ▼ Sell | Open Market | 19,404 | $1.2M | 3/3/2025 | View on chart |
| SYF | ▼ Sell | Open Market | 363 | $22K | 3/3/2025 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 15,518 | $942K | 3/1/2025 | View on chart |
| SYF | ▲ Buy | Grant | 24,102 | $1.5M | 3/1/2025 | View on chart |
| SYF | ▲ Buy | Grant | 256 | $17K | 2/18/2025 | View on chart |
| SYF | ▲ Buy | Grant | 68,246 | $4.7M | 1/21/2025 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 29,557 | $2.1M | 1/21/2025 | View on chart |
| SYF | ▲ Buy | Grant | 256 | $17K | 11/15/2024 | View on chart |
| SYF | ▲ Buy | Grant | 361 | $17K | 8/15/2024 | View on chart |
| SYF | ▼ Sell | Open Market | 443 | $23K | 8/1/2024 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 384 | $18K | 7/1/2024 | View on chart |
| SYF | ▲ Buy | Grant | 378 | $17K | 5/15/2024 | View on chart |
| SYF | ▲ Buy | Option Exercise | 17,177 | $504K | 3/5/2024 | View on chart |
| SYF | ▲ Buy | Option Exercise | 11,436 | $348K | 3/5/2024 | View on chart |
| SYF | ▼ Sell | Open Market | 71,496 | $2.9M | 3/5/2024 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 13,596 | $558K | 3/1/2024 | View on chart |
| SYF | ▲ Buy | Grant | 31,791 | $1.3M | 3/1/2024 | View on chart |
| SYF | ▲ Buy | Grant | 401 | $16K | 2/15/2024 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 16,365 | $621K | 1/24/2024 | View on chart |
| SYF | ▲ Buy | Grant | 43,507 | $1.7M | 1/24/2024 | View on chart |
| SYF | ▼ Sell | Open Market | 5,173 | $197K | 12/14/2023 | View on chart |
| SYF | ▼ Sell | Open Market | 5,023 | $186K | 12/13/2023 | View on chart |
| SYF | ▼ Sell | Open Market | 533 | $19K | 12/12/2023 | View on chart |
| SYF | ▲ Buy | Grant | 543 | $16K | 11/9/2023 | View on chart |
| SYF | ▲ Buy | Grant | 457 | $16K | 8/10/2023 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 374 | $13K | 7/1/2023 | View on chart |
| SYF | ▲ Buy | Grant | 536 | $15K | 5/12/2023 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 1,023 | $30K | 4/1/2023 | View on chart |
| SYF | ▼ Sell | Open Market | 4,490 | $162K | 3/3/2023 | View on chart |
| SYF | ▲ Buy | Grant | 34,395 | $1.2M | 3/1/2023 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 11,752 | $423K | 3/1/2023 | View on chart |
| SYF | ▼ Sell | Open Market | 27,804 | $1.0M | 2/27/2023 | View on chart |
| SYF | ▲ Buy | Grant | 360 | $13K | 2/17/2023 | View on chart |
| SYF | ▲ Buy | Grant | 44,196 | $0 | 1/24/2023 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 16,391 | $580K | 1/24/2023 | View on chart |
| SYF | ▼ Sell | Open Market | 31,303 | $1.3M | 11/11/2022 | View on chart |
| SYF | ▲ Buy | Grant | 330 | $13K | 11/10/2022 | View on chart |
| SYF | ▲ Buy | Grant | 352 | $13K | 8/11/2022 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 363 | $10K | 7/1/2022 | View on chart |
| BHF | ▲ Buy | Option Exercise | 1,791 | $0 | 6/8/2022 | View on chart |
| SYF | ▲ Buy | Grant | 371 | $12K | 5/12/2022 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 1,853 | $65K | 4/1/2022 | View on chart |
| SYF | ▲ Buy | Grant | 29,643 | $1.2M | 3/1/2022 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 9,267 | $366K | 3/1/2022 | View on chart |
| SYF | ▲ Buy | Grant | 251 | $11K | 2/17/2022 | View on chart |
| SYF | ▲ Buy | Grant | 217 | $11K | 11/12/2021 | View on chart |
| SYF | ▼ Sell | Tax Withholding | 9,683 | $446K | 1/26/2021 | View on chart |
| SYF | ▲ Buy | Grant | 27,695 | $0 | 1/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Synchrony Financial Prepares for Q3 Earnings Amid Mixed Analyst Views
Synchrony Financial is approaching its third-quarter earnings report, with analysts expecting lower results compared to previous periods. While some market participants are watching for higher purchase volumes to support performance, recent stock price movements have been volatile. The company's current valuation remains low relative to its peer group, and its preferred shares have seen increased interest due to yield.
Synchrony Financial Prepares for Q3 Earnings Amid Mixed Analyst Views. Synchrony Financial is approaching its third-quarter earnings report, with analysts expecting lower results compared to previous periods. While some market participants are watching for higher purchase volumes to support performance, recent stock price movements have been volatile. The company's current valuation remains low relative to its peer group, and its preferred shares have seen increased interest due to yield.